Eli Lilly LLY
NYSE LLY
$1,421.81 +9.86 (+0.70%)
As of: Nov 10, 2026 · 12:58 PM EST

Eli Lilly (LLY) Share-based Compensation (2009 - 2026)

Updated

Eli Lilly (LLY) posted Share-based Compensation of $200 million for Q3 2026, up 32.5% from $151 million a year earlier but down 0.5% from the prior quarter.

Analysis

Eli Lilly (LLY) Share-based Compensation (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Share-based Compensation at Eli Lilly was $698 million, up 10.4% year-over-year; for FY2025, it was $626 million, down 3.1% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 15.2% (FY2020 to FY2025).
  • In prior years, Eli Lilly's Share-based Compensation was $646 million in FY2024 (+2.7%), $629 million in FY2023 (+69.5%), $371.1 million in FY2022 (+8.3%) and $342.8 million in FY2021 (+11.3%).
  • Quarterly Share-based Compensation has run from a low of $75.3 million in Q4 2021 to a high of $215.6 million in Q3 2023 over five years.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last three quarters, with growth averaging 7.1% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2023, with growth of 153.3%; the weakest was Q3 2024, with a decline of 38.2%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $201 million (Q2 2026), $161 million (Q1 2026) and $136 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 Vertex Pharmaceuticals 138.78 Bn 110.77 Bn 2.91 Bn 174.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 200.00 Mn
Jun 30, 2026 201.00 Mn
Mar 31, 2026 161.00 Mn
Dec 31, 2025 136.00 Mn
Sep 30, 2025 151.00 Mn
Jun 30, 2025 185.00 Mn
Mar 31, 2025 154.00 Mn
Dec 31, 2024 142.30 Mn
Sep 30, 2024 133.20 Mn
Jun 30, 2024 211.10 Mn
Mar 31, 2024 159.40 Mn
Dec 31, 2023 120.70 Mn
Sep 30, 2023 215.60 Mn
Jun 30, 2023 161.50 Mn
Mar 31, 2023 131.20 Mn
Dec 31, 2022 92.90 Mn
Sep 30, 2022 85.10 Mn
Jun 30, 2022 92.10 Mn
Mar 31, 2022 101.00 Mn
Dec 31, 2021 75.30 Mn
API Access

Eli Lilly Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LLY&period=max&api_key=YOUR_API_KEY